Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$276.36 - $326.03 $1.48 Million - $1.74 Million
5,350 Added 126.93%
9,565 $3.05 Million
Q4 2022

Feb 14, 2023

SELL
$212.22 - $313.46 $297,108 - $438,844
-1,400 Reduced 24.93%
4,215 $1.24 Million
Q3 2022

Nov 14, 2022

SELL
$224.6 - $281.45 $471,660 - $591,045
-2,100 Reduced 27.22%
5,615 $1.29 Million
Q2 2022

Aug 15, 2022

SELL
$186.4 - $279.02 $279,600 - $418,530
-1,500 Reduced 16.28%
7,715 $1.68 Million
Q4 2021

Feb 14, 2022

SELL
$255.32 - $318.29 $1.15 Million - $1.43 Million
-4,500 Reduced 32.81%
9,215 $2.45 Million
Q3 2021

Nov 12, 2021

BUY
$260.36 - $307.27 $416,576 - $491,632
1,600 Added 13.21%
13,715 $3.9 Million
Q2 2021

Aug 13, 2021

BUY
$225.52 - $304.06 $1.69 Million - $2.28 Million
7,500 Added 162.51%
12,115 $3.33 Million
Q1 2021

May 19, 2021

BUY
$235.95 - $293.05 $448,305 - $556,795
1,900 Added 69.98%
4,615 $1.2 Million
Q4 2020

Feb 12, 2021

BUY
$215.97 - $265.89 $222,449 - $273,866
1,030 Added 61.13%
2,715 $694,000
Q2 2020

Aug 14, 2020

BUY
$159.17 - $224.73 $31,833 - $44,946
200 Added 13.47%
1,685 $327,000
Q1 2020

May 15, 2020

SELL
$130.01 - $216.44 $26,002 - $43,288
-200 Reduced 11.87%
1,485 $246,000
Q4 2019

Feb 18, 2020

SELL
$144.81 - $186.0 $47,352 - $60,822
-327 Reduced 16.25%
1,685 $288,000
Q3 2019

Nov 14, 2019

SELL
$117.35 - $167.95 $129,085 - $184,745
-1,100 Reduced 35.35%
2,012 $332,000
Q2 2019

Aug 15, 2019

BUY
$82.13 - $120.73 $8,213 - $12,073
100 Added 3.32%
3,112 $372,000
Q1 2019

May 15, 2019

BUY
$72.44 - $101.87 $108,442 - $152,499
1,497 Added 98.81%
3,012 $286,000
Q4 2018

Feb 14, 2019

BUY
$73.27 - $105.19 $44,694 - $64,165
610 Added 67.4%
1,515 $120,000
Q3 2018

Nov 14, 2018

BUY
$81.43 - $108.13 $73,694 - $97,857
905 New
905 $96,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.